Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: CIHR Fellowship

University of Toronto

$135,000.00

Structural and Functional Characterization of Hsp104/ClpB Protein Disaggregating Chaperone Machinery.

EF 2011-12

Résumé
Several human diseases are caused by protein misfolding and the accumulation of toxic protein aggregates. These include Alzheimer's and Parkinson's diseases, type II diabetes and the spongiform encephalopathies such as Creutzfeldt-Jakob disease. In order to develop effective therapeutic strategies to prevent, slow-down or reverse the progression of these diseases, we must, therefore, first understand the molecular mechanism involved in triggering and/or reversing protein aggregation in vivo. Hsp104/ClpB chaperones have the ability to bind and to remodel non-natively folded polypeptides, i.e. reverse protein aggregation in their host cells; however the molecular mechanisms underlying the disaggregase function are complex and not yet fully understood. The current model suggests that Hsp104/ClpB proteins break down large aggregates and recover proteins from a non-native insoluble or aggregated state with the help of the Hsp70/40 chaperone system. Studying the structure-function relationship of ClpB/Hsp104 presents a unique opportunity for determining how protein aggregation is modulated and reversed in nature and for developing strategies to prevent or treat protein misfolding diseases. Nuclear Magnetic Resonance is an ideal method for the study of dynamic complexes, such as Hsp104/ClpB, and by utilizing and expanding upon the innovative techniques developed at the Kay laboratory, we plan to elucidate the modus operandi of these chaperones. Among our goals are to characterize Hsp104/ClpB interactions with other cellular chaperones, how substrates enter the complexes, and what the conformational changes the enzymes undergo when they consume energy. This research should paint a clearer picture of how these essential molecular machines function, as well as provide insight into the biochemistry of ClpB/Hsp104, transcending static three-dimensional structures and shedding light on the dynamics, and thus the function, of these complexes.
Programme
CIHR Fellowship
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
242279
Name
Rosenzweig Rina
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Neurosciences, Mental Health and Addiction
Theme2
Biomedical
Prcname2
Fellowships - Post-PhD
Projecttitle
Structural and Functional Characterization of Hsp104/ClpB Protein Disaggregating Chaperone Machinery.
Programtype2
Fellowship Programs
Orgnameinp2
University of Toronto
Cihramount2
$135,000
Cihrequipment2
$0
Programname2
CIHR Fellowship
Keyworddelim
Biochemistry; Biophysics; Neurodegenerative Disorders; Nmr; Protein Disaggregation; Protein-Protein Interactions
Abstract
Several human diseases are caused by protein misfolding and the accumulation of toxic protein aggregates. These include Alzheimer's and Parkinson's diseases, type II diabetes and the spongiform encephalopathies such as Creutzfeldt-Jakob disease. In order to develop effective therapeutic strategies to prevent, slow-down or reverse the progression of these diseases, we must, therefore, first understand the molecular mechanism involved in triggering and/or reversing protein aggregation in vivo. Hsp104/ClpB chaperones have the ability to bind and to remodel non-natively folded polypeptides, i.e. reverse protein aggregation in their host cells; however the molecular mechanisms underlying the disaggregase function are complex and not yet fully understood. The current model suggests that Hsp104/ClpB proteins break down large aggregates and recover proteins from a non-native insoluble or aggregated state with the help of the Hsp70/40 chaperone system. Studying the structure-function relationship of ClpB/Hsp104 presents a unique opportunity for determining how protein aggregation is modulated and reversed in nature and for developing strategies to prevent or treat protein misfolding diseases. Nuclear Magnetic Resonance is an ideal method for the study of dynamic complexes, such as Hsp104/ClpB, and by utilizing and expanding upon the innovative techniques developed at the Kay laboratory, we plan to elucidate the modus operandi of these chaperones. Among our goals are to characterize Hsp104/ClpB interactions with other cellular chaperones, how substrates enter the complexes, and what the conformational changes the enzymes undergo when they consume energy. This research should paint a clearer picture of how these essential molecular machines function, as well as provide insight into the biochemistry of ClpB/Hsp104, transcending static three-dimensional structures and shedding light on the dynamics, and thus the function, of these complexes.
Competitiondate
201110
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Rosenzweig, Rina
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $135,000~ $0~